Portal de Periódicos da CAPES

The Anti‐Ro Antibody System

1986; Wiley; Volume: 25; Issue: 1 Linguagem: Inglês

10.1111/j.1365-4362.1986.tb03395.x

1365-4632

Sharon R. Hymes, Thomas J. Russell, Robert E. Jordon,

Monoclonal and Polyclonal Antibodies Research

International Journal of DermatologyVolume 25, Issue 1 p. 1-7 The Anti-Ro Antibody System Sharon R. Hymes M.D., Corresponding Author Sharon R. Hymes M.D. Cutaneous Immunopathology Unit and the Department of Dermatology, The University of Texas Health Science Center, Houston, Texas, and the Division of Dermatology, The Medial College of Wisconsin, Milwaukee, WisconsinSharon R. Hymes, M.D., Department of Dermatology, The University of Texas Medical School at Houston, 6431 Fannin, Suite 1.204, Houston, TX 77030.Search for more papers by this authorThomas J. Russell M.D., Thomas J. Russell M.D. Cutaneous Immunopathology Unit and the Department of Dermatology, The University of Texas Health Science Center, Houston, Texas, and the Division of Dermatology, The Medial College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this authorRobert E. Jordon M.D., Robert E. Jordon M.D. Cutaneous Immunopathology Unit and the Department of Dermatology, The University of Texas Health Science Center, Houston, Texas, and the Division of Dermatology, The Medial College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this author Sharon R. Hymes M.D., Corresponding Author Sharon R. Hymes M.D. Cutaneous Immunopathology Unit and the Department of Dermatology, The University of Texas Health Science Center, Houston, Texas, and the Division of Dermatology, The Medial College of Wisconsin, Milwaukee, WisconsinSharon R. Hymes, M.D., Department of Dermatology, The University of Texas Medical School at Houston, 6431 Fannin, Suite 1.204, Houston, TX 77030.Search for more papers by this authorThomas J. Russell M.D., Thomas J. Russell M.D. Cutaneous Immunopathology Unit and the Department of Dermatology, The University of Texas Health Science Center, Houston, Texas, and the Division of Dermatology, The Medial College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this authorRobert E. Jordon M.D., Robert E. Jordon M.D. Cutaneous Immunopathology Unit and the Department of Dermatology, The University of Texas Health Science Center, Houston, Texas, and the Division of Dermatology, The Medial College of Wisconsin, Milwaukee, WisconsinSearch for more papers by this author First published: January 1986 https://doi.org/10.1111/j.1365-4362.1986.tb03395.xCitations: 25 Supported in part by research grants Al-14550 and AM-32974. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Clark GM, Reichlin M, Tomasi TB. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol. 1968; 102: 117– 122. 2 Lerner MR, Boyle JA, Hardin JA, et al. Two novel classes of small RNA proteins detected by antibodies associated with lupus erythematosus. Science. 1981; 211: 400– 402. 3 Lerner EA, Lerner MR, Hardin JA, et al. Deciphering the mysteries of RNA-containing lupus antigens. Arthritis Rheum. 1982; 25: 761– 766. 4 Wolin SL, Steitz JA. The Ro small cytoplasmic proteins: identification of the antigenic protein and its binding site on the Ro RNAs. Proc Natl Acad Sci USA. 1984; 81: 1996– 2000. 5 Mattioli M, Reichlin M. Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosis: description of a cytoplasmic non-ribosomal antigen. Arthritis Rheum. 1974; 17: 421– 429. 6 Alspaugh MA, Tan EM. Antibodies to cellular antigens in Sjogren'3s syndrome. J Clin Invest. 1975; 55: 1067– 1073. 7 Alspaugh MA, Maddison P. Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and Sjogren'3s syndrome: an interfaboratory collaboration. Arthritis Rheum, 1979; 22: 796– 798. 8 Harmon CE, Deng JS, Peebles CL, et al. The importance of tissue substrate in the SSA/Ro antigen-antibody system. Arthritis Rheum. 1984; 27: 116– 173. 9 Alexander EL, Provost TT. Ro(SSA) and La(SSB) antibodies. Springer Semin Immunopathol. 1981; 4: 253– 273. 10 Maddison PJ, Provost TT, Reichlin M. Serologic findings in patients with "ANA negative" systemic lupus erythematosus. Medicine. 1981; 60: 87– 94. 11 Maddison P, Mogavero H, Provost TT, et al. The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases, J Rheumatol. 1979; 6: 189– 195. 12 Scopelitis E, Biundo JJ, Alspaugh MA. Anti-SSA antibody and other antinuclear antibodies in systemic lupus erythematosus. Arthritis Rheum. 1980; 23: 287– 293. 13 Bell DA, Maddison PJ. Serologic subsets In systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum. 1980; 23: 1268– 1273. 14 Ahearn JM, Provost TT, Dorsch CA, et al. Interrelationships of HLA-DR, MB and MT phenotype, autoantibody expression and clinical features in systemic lupus erythematosus. Arthritis Rheum. 1982; 25; 1031– 1040. 15 Arnett FC, Reveille JD, Wilson RW, et al. Systemic lupus erythematosus: current state of the genetic hypothesis. Semin Arthritis Rheum. 1984; 14: 24– 35. 16 Moutsopoulos HM, Klippel JH, Pavlidis N, et al. Correlative histologic and serologic findings of sicca syndrome in patients with systemic lupus erythematosus. Arthritis Rheum. 1980; 23: 36– 40. 17 Reichlin M. Clinical and immunological significance of antibodies to Ro and La in systemic lupus erythematosus. Arthritis Rheum. 1982; 25: 767– 772. 18 Catoggio LJ, Skinner RP, Smith G, et al. Systemic lupus erythematosus in the elderly: clinical and serological associations. J Rheumatol. 1984; 11: 175– 181. 19 Hochberg MC, Boyd RE, Ahearn JM, et al. Systemic lupus erythematosus: a review of clinicolaboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore). 1985; 64: 285– 295. 20 Wasicek CA, Reichlin M. Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest. 1982; 69: 835– 843. 21 Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol. 1979; 115: 1409– 1415. 22 Cohen AS, Reynolds WE, Franklin EC, et al. Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis. 1971; 21: 643– 648. 23 Sontheimer RD, Maddison PJ, Reichlin M, et al. Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med. 1982; 97: 664– 671. 24 Sontheimer RD, Stastny P, Gilliam JN. Human histocompatibility antigen association in subacute cutaneous lupus erythematosus. J Clin Invest. 1981; 67: 312– 316. 25 Gladman DD, Chalmers A, Urowitz MB. Systemic lupus erythematosus with negative LE cells and antinuclear factor. J Rheumatol. 1978; 5: 142– 147. 26 Fessel WJ. ANA-negative systemic lupus erythematosus. Am J Med. 1978: 64: 80– 86. 27 Bohan A. Seronegative systemic lupus erythematosus. J Rheumatol. 1979; 6: 534– 540. 28 Rothschild BM, Jones JV, Chesney C, et al. Relationship of clinical findings in systemic lupus erythematosus to seroreactivity. Arthritis Rheum. 1983; 26: 45– 51. 29 Provost TT. Subsets of systemic lupus erythematosus. J. Invest Dermatol, 1979; 72: 110– 113. 30 Provost TT, Reichlin M. Antinuclear antibody-negative systemic lupus erythematosus: I, Anti-Ro(SSA) and anti-La(SSB) antibodies. J Am Acad Dermatol, 1981; 4: 84– 89. 31 Wermuth DJ, Geoghegan WD, Jordon RE. Anti-Ro(SSA) antibodies: association with a particulate (large speckled-like thread) immunofluorescent nuclear staining pattern. Arch Dermatol. 1985; 121: 335– 338. 32 Deng JS, Sontheimer RD, Gilliam JN. Relationships between antinuclear and anti-Ro/SSA antibodies in subacute cutaneous lupus erythematosus. J Am Acad Dermatol. 1984; 11: 494– 499. 33 Dore N, Synkowski D, Provost TT. Antinuclear antibody determinations in Ro(SSA)-positive, antinuclear antibody-negative lupus and Sjongren'3s syndrome patients. J Am Acad Dermatol. 1983; 8: 611– 615. 34 Burnham TK. Antinuclear antibodies: a simplified classification of the nuclear immunofluorescent patterns. Arch Dermatol. 1978; 114: 1343– 1344. 35 Provost TT, Arnett FC, Reichlin M. Homozygous C2 deficiency, lupus erythematosus, and anti-Ro(SSA) antibodies. Arthritis Rheum. 1983; 26: 1279– 1282. 36 Agnello V. Association of systemic lupus erythematosus and SLE-like syndrome with hereditary and acquired complement deficiency states, Arthritis Rheum. 1978; 21: S146– S152. 37 Osterland CK, Espinoza L, Parker LP, et al. Inherited C2 deficiency and systemic lupus erythematosus: studies on a family. Ann Intern Med. 1978; 82: 323– 328. 38 Kohler P. Inherited complement deficiencies and systemic lupus erythematosus: an immunologic puzzle. Ann Intern Med. 1975; 82: 1420– 1421. 39 Agnello V. Complement deficiency states. Medicine. 1978; 57: 1– 23. 40 Schur PH. Complement and lupus erythematosus. Arthritis Rheumatol. 1982; 25: 793– 798. 41 Glass D, Raum D, Gibson D, et al. Inherited deficiency of the second component of complement. J. Clin Invest. 1976; 58: 853– 861. 42 Levy SB, Pinnell SR, Meadows L, et al. Hereditary C2 deficiency associated with cutaneous lupus erythematosus, Arch Dermatol. 1979; 115: 57– 61. 43 Vanderstein PR, Provost TT, Jordon RE, et al. C2 deficient systemic lupus erythematosus. Arch Dermatol, 1982; 118: 584– 587. 44 Raum D, Glass D, Carpenter CB, et al. Mapping of the structural gene of the second component of complement with respect to the major histocompatibility complex. Am J Hum Genet. 1979: 31: 35– 41. 45 Tappeiner G, Hinter H, Scholz S, et al. Systemic lupus erythematosus in hereditary deficiency of the fourth component of complement, J Am Acad Dermatol. 1982; 7: 66– 79. 46 McCuistion CH, Schoch EP Jr. Possible discoid lupus erythematosus in the newborn infant. Arch Dermatol. 1954; 70: 782– 785. 47 Watson RM, Lane AT, Barnett NK, et al. Neonatal lupus erythematosus: a clinical, serological and immunogenetic study with review of the literature. Medicine. 1984; 63: 362– 378. 48 Lumpkin LR, Hall JR, Hogan JD, et al. Neonatal lupus erythematosus: a report of three cases associated with anti-Ro/SSA antibodies. Arch Dermatol. 1985; 121: 377– 381. 49 East WR, Lumpkin LR. Systemic lupus erythematosus in the newborn. Minn Med, 1969; 52: 477– 478. 50 Vonderheld EC, Koblenzer PJ, Ming PM, et al. Neonatal lupus erythematosus: report of four cases with review of the literature. Arch Dermatol, 1976; 112: 698– 705. 51 Hardy JD, Solomon S, Banwell GS, et al. Congenital complete heart block in the newborn associated with maternal systemic lupus erythematosus and other connective tissue disorders. Arch Dis Child, 1979; 54: 7– 13. 52 Franco HL, Weston WL, Peebles C, et al. Autoantibodies directed against sicca syndrome in the neonatal lupus syndrome. J Am Acad Dermatol. 1981; 4: 67– 72. 53 Winkler RB, Nora AH, Nora JJ. Familial congenital complete heart block and maternal systemic lupus erythematosus. Circulation, 1977; 56: 1103– 1106. 54 Esscher E, Scott JS. Congenital heart block and maternal systemic lupus erythematosus, Br Med J. 1979; 2: 1235– 1238. 55 Draznin TH, Esterly NB, Furey N L, et al. Neonatal lupus erythematosus. J Am Acad Dermatol. 1979; 1: 437– 442. 56 Vetter VL, Rashkind WJ. Congenital complete heart block and connective tissue disease. N Engl J Med. 1983; 309: 236– 238. 57 Scott JS, Maddison PJ, Taylor PV, et al. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med. 1983; 309: 209– 212. 58 Lockshin MD, Gibofsky A, Peebles CL, et al. Neonatal lupus erythematosus with heart block: family study of a patient with anti-SSA and SSB antibodies. Arthritis Rheum. 1983; 26: 210– 213. 59 McCue CM, Mantakas ME, Tinglestad JB, et al. Congenital heart block in newborns of mothers with connective tissue disease. Circulation, 1977: 56: 82– 90. 60 Chameides L, Truex RC, Vetter V, et al. Association of maternal lupus erythematosus with congenital complete heart block. N Engl J Med. 1977; 297: 1204– 1207. 61 Hull D, Binns BAO, Joyce D. Congenital heart block and wide spread fibrosis due to maternal lupus erythematosus. Arch Dis Child. 1966: 41: 688– 690. 62 Franco HL, Weston WL, Tan EM, et al. Association of antibodies to sicca syndrome antigens in newborns with lupus erythematosus and their mothers. Clin Res. 1980; 28: 134a. 63 Harmon CE, Lee L A, Huff JC, et al. The frequency of antibodies to the SS-A/Ro antigen in pregnancy sera (abstract). Arthritis Rheum 1984; 27: S20. 64 Lee LA, Bias WB, Arnett FC Jr. et al. Immunogenetics of the neonatal lupus syndrome. Ann Intern Med, 1983; 99: 592– 596. 65 Moutsopoulos HM, Webber BL, Vlagopoulos TP, et al. Differences in the clinical manifestations of the sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med. 1979; 66: 733– 736. 66 Elkon KB, Gharavi AE, Hughes GR, et al. Autoantibodies in the sicca syndrome (primary Sjogren'3s syndrome), Ann Rheum Dis. 1984; 43: 243– 245. 67 Talal N, Sokoloff L, Barth WF. Extrasalivary lymphoid abnormalities in Sjogren'3s syndrome (reticulum cell sarcoma, "pseudolymphoma," macroglobulinemia). Am J Med, 1967; 43: 50– 65. 68 Alspaugh MA, Buchanan WW, Whaley K. Precipitating antibodies to cellular antigens in Sjogren'3s syndrome, rheumatoid arthritis and other organ and nonorgan-specific autoimmune diseases. Ann Rheum Dis, 1978: 37: 244– 246. 69 Alexander EL, Hirsch TJ, Arnett FC, et al. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjogren'3s syndrome. J Rheumatol, 1982; 9: 239– 246. 70 Alspaugh MA, Talal N, Tan EM. Differentiation and characterization of autoantibodies and their antigens in Sjogren'3s syndrome. Arthritis Rheum. 1976; 19: 216– 222. 71 Martinez-Lavin M, Vaughan JH, Tan EM. Autoantibodies and the spectrum of Sjogren'3s syndrome, Ann Intern Med. 1979; 91: 185– 190. 72 Alexander EL, Arnett FC, Provost TT, et al. Sjogren'3s syndrome: association of anti-Ro(SSA) antibodies with vasculitis, hematologic abnormalities and serologic hyperreactivity. Ann Intern Med, 1983; 98: 155– 159. 73 Alexander EL, Provost TT. Cutaneous manifestations of primary Sjogren'3s syndrome: a reflection of vasculitis and association with anti-Ro(SSA) antibodies. I Clin Invest, 1983; 80: 386– 391. 74 Harley JB, Alexander EL, Arnett FC, et al. Relationships of relative quantitative levels of anti Ro(SSA), La(SSB), and nRNP (Sm) to the clinical manifestations of Sjogren'3s syndrome (abstract). Arthritis Rheum. 1984; 27: S46. 75 Maddison PJ, Reichlin M. Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus, Arthritis Rheum, 1979; 22: 858– 863. 76 Lefeber WP, Norris DA, Ryan SR, et al. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. I Clin Invest 1984: 74: 1545– 1551. 77 Norris DA, Ryan SR, Fritz KA, et al. The role of RNP, Sm and SSA specific antisera from patients with lupus erythematosus in inducing antibody dependent cellular cytotoxicity (ADCC) of ribonucleoprotein-located targets (abstract), Clin Res. 1982; 30: 264a. 78 Sontheimer RD. Immunobiological significance of the Ro/SSA antigen-antibody system. Arch Dermatol, 1985; 121: 327– 329. Citing Literature Volume25, Issue1January 1986Pages 1-7 ReferencesRelatedInformation